| Drug Name: | Certolizumab pegol (428863-50-7) |
|---|---|
| PubChem ID: | 124080985 |
| SMILES: | CC(C)[C@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5C[C@@H]6[C@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O |
| InchiKey: | SPXACGZWWVIDGR-QDKBDMIYSA-N |
| Therapeutic Category: | Immunologic Factors, Immunosuppressive Agents |
| Molecular Weight (dalton) | : | 707.85 |
| LogP | : | 2.2212 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 172.58 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category